NCUK Virtual Summit
Free annual event for patients and supporters to learn about all aspects of Neuroendocrine Cancer.
Welcome to the NCUK Virtual Summit 2020
We’re excited to present a weekend-long schedule full of passionate Neuroendocrine Cancer experts, specialists and members of the community, sharing their experience and knowledge through our virtual classrooms! You can watch all of the sessions or just dip in and out as you please… and all from the comfort of your own home.
To close the event, on World NET Cancer Day (November 10th), we will be hosting our own NCQT… ‘Neuroendocrine Cancer Question Time’, where you will be able to watch the Summit LIVE and submit your questions to a panel of experts.
Our virtual sessions will be available to watch on the 7th and 8th November 2020.
The NCQT event will be live-streamed from London direct to your homes on Tuesday 10th November 2020 from 2:00pm – 4:00pm.
Please note that if you are unable to join then the full Summit, presentations and the live-stream recording will be made available after the event on our website.
How much is the event?
The NCUK Virtual Summit is completely free, but we would welcome donations.
All sessions and the NCQT event will be held through a password protected forum.
Once registration is complete we will email you details of how to join the Summit.
Interactive workshops, for specific Neuroendocrine Cancer types and including;
- Global research into NETs and understanding research
- Emotional Wellbeing
- Becoming your own expert.
We’d love to hear your feedback about the event.
** YOU WILL BE ABLE TO SUBMIT YOUR FEEDBACK AFTER THE EVENT, THANK YOU**
NCUK Sponsored Local Hospital Patient Events
Alongside our Summit, we also support events in collaboration with local NET clinics who would like to run local education sessions where agendas and venues are sorted locally. Please get in touch for further information.
Neuroendocrine Cancer UK is a UK wide charity solely dedicated to providing support and information to those affected by Neuroendocrine Cancer.
Subscribe to our Newsletter to stay update with our latest news.